139 related articles for article (PubMed ID: 22407111)
21. Fluvoxamine treatment of a child with severe PDD: a single case study.
Kauffmann C; Vance H; Pumariega AJ; Miller B
Psychiatry; 2001; 64(3):268-77. PubMed ID: 11708052
[TBL] [Abstract][Full Text] [Related]
22. Fluoxetine in children with autism.
Peral M; Alcamà M; Gilaberte I
J Am Acad Child Adolesc Psychiatry; 1999 Dec; 38(12):1472-3. PubMed ID: 10596244
[No Abstract] [Full Text] [Related]
23. Possible role of caffeine in autism spectrum disorders, a new testable hypothesis.
Ghanizadeh A
J Food Sci; 2010 Aug; 75(6):ix. PubMed ID: 20722962
[No Abstract] [Full Text] [Related]
24. Use of selective serotonin reuptake inhibitors in childhood depression.
Wohlfarth T; Lekkerkerker F; van Zwieten B
Lancet; 2004 Aug 21-27; 364(9435):659-60; author reply 661. PubMed ID: 15325820
[No Abstract] [Full Text] [Related]
25. SSRI and EPS with fluoxetine.
Jones-Fearing KB
J Am Acad Child Adolesc Psychiatry; 1996 Sep; 35(9):1107-8. PubMed ID: 8824052
[No Abstract] [Full Text] [Related]
26. Should selective serotonin reuptake inhibitors be prescribed for children with major depressive and anxiety disorders?
Safer DJ
Pediatrics; 2006 Sep; 118(3):1248-51. PubMed ID: 16951019
[No Abstract] [Full Text] [Related]
27. Outcome of children exposed in utero to fluoxetine: a critical review.
Koren G; Nulman I; Addis A
Depress Anxiety; 1998; 8 Suppl 1():27-31. PubMed ID: 9809211
[No Abstract] [Full Text] [Related]
28. Fluoxetine for depression relapse prevention.
Calarge C; Kuperman S
J Am Acad Child Adolesc Psychiatry; 2005 Oct; 44(10):966-7; author reply 967-8. PubMed ID: 16175095
[No Abstract] [Full Text] [Related]
29. Use of SSRIs in children.
Bienert SE
J Fam Pract; 1998 Feb; 46(2):118. PubMed ID: 9487315
[No Abstract] [Full Text] [Related]
30. [Neuroadaptive changes in brain during selective serotonin reuptake inhibitors action].
Shishkina GT
Ross Fiziol Zh Im I M Sechenova; 2007 Nov; 93(11):1245-51. PubMed ID: 18198592
[TBL] [Abstract][Full Text] [Related]
31. Selective serotonin reuptake inhibitors plus pindolol.
Terao T
Lancet; 1997 Jul; 350(9073):289. PubMed ID: 9242817
[No Abstract] [Full Text] [Related]
32. Ten years of fluoxetine.
Stokes PE
Depress Anxiety; 1998; 8 Suppl 1():1-4. PubMed ID: 9809207
[No Abstract] [Full Text] [Related]
33. Fluoxetine for serotonin reuptake inhibitor discontinuation syndrome.
Benazzi F
J Psychiatry Neurosci; 1998 Sep; 23(4):241-2. PubMed ID: 9785704
[No Abstract] [Full Text] [Related]
34. Fluoxetine and eating disorders.
Morgan JF
Hosp Med; 1999 Sep; 60(9):686. PubMed ID: 10621803
[No Abstract] [Full Text] [Related]
35. Sertraline-induced enuresis in a prepubertal child resolves after switching to fluoxetine.
Maalouf FT; Gilbert AR
J Child Adolesc Psychopharmacol; 2010 Apr; 20(2):161-2. PubMed ID: 20415614
[No Abstract] [Full Text] [Related]
36. Psychopharmacology of autistic spectrum disorders in children and adolescents.
Nazeer A
Pediatr Clin North Am; 2011 Feb; 58(1):85-97, x. PubMed ID: 21281850
[TBL] [Abstract][Full Text] [Related]
37. Time-to-effect of fluoxetine in children with depression.
Yan T; Goldman RD
Can Fam Physician; 2019 Aug; 65(8):549-551. PubMed ID: 31413023
[No Abstract] [Full Text] [Related]
38. Use of selective serotonin reuptake inhibitors in childhood depression.
Curtin F; Schulz P
Lancet; 2004 Aug 21-27; 364(9435):660; author reply 661. PubMed ID: 15325821
[No Abstract] [Full Text] [Related]
39. Fluoxetine in the treatment of self-mutilating behavior.
Velazquez L; Ward-Chene L; Loosigian SR
J Am Acad Child Adolesc Psychiatry; 2000 Jul; 39(7):812-4. PubMed ID: 10892222
[No Abstract] [Full Text] [Related]
40. Fluoxetine: therapeutic and undesirable effects.
Cookson J; Duffett R
Hosp Med; 1998 Aug; 59(8):622-6. PubMed ID: 9829055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
